Hepatitis B surface antigen clearance in lamivudine-treated patients: main therapeutic goal?
Santantonio
Teresa
T
Fasano
Massimo
M
Palattella
Stefania
S
Pastore
Giuseppe
G
D006514:Hepatitis B Surface Antigens / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D006514:Hepatitis B Surface Antigens; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine